Naver buys minority stake in streaming platform Tving Deal likely to give internet giant upper hand over rival Coupang in digital content industry
Translated by Ryu Ho-joung 공개 2021-07-02 07:33:50
이 기사는 2021년 07월 02일 07:32 thebell 에 표출된 기사입니다.
Naver Corp has bought a minority stake in Tving, CJ ENM’s streaming service, in a deal that is likely to give the South Korean internet giant the upper hand over rival Coupang in the digital content industry.A regulatory filing on Wednesday revealed that Naver acquired 261,817 shares, or 15.38% in the streaming platform in a private placement.
The stake purchase follows the share swap between Naver and CJ Group in October 2020, which allowed Naver to secure a 6.26% stake in Studio Dragon, CJ’s drama production studio, and a 4.996% stake in CJ ENM, which owns TV channels including tvN.
The partnership aimed for synergy between Naver’s intellectual properties of digital comics and CJ’s production and broadcasting operations.
Naver intends to use the latest deal to expand its ecommerce user base, industry watchers said. Ecommerce players at home and abroad have increasingly launched streaming services in a bid to make users spend more time on their platforms. Ecommerce giant Coupang also launched its own streaming service, Coupang Play, last year.
Naver has been strengthening its partnership with Tving. It began in March to allow Naver Plus users free access to content on Tving.
Naver is expected to step up investment in the content business. In January, it announced the acquisition of Canada-based social storytelling platform Wattpad. After the deal closed, studio divisions of the two companies were merged to create Wattpad Webtoon Studios. (Reporting by Pil-woo Choi)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- [보험사 지급여력 돋보기]DB손보, 줄어든 '보험위험'에 버퍼 확보
- AI 외치는 삼성, 자신감·위기감 '공존'
- 시큐센, 1분기 매출 41억·영업손실 13억
- 콤텍시스템, 1분기 적자폭 감소 "AI 공격 투자"
- '어닝서프라이즈' 파워넷 "성장 모멘텀 계속"
- '이 어려운 시기에'...KB증권, 동문건설 '본PF' 성공
- '청산 수순' 빗썸메타, 마무리 투수 '최대열 대표' 등판
- '금 견인' 아이티센, 역대 1분기 최대 매출 달성
- '탈모사업 선전' 메타랩스, 1분기 매출 115%↑
- [HLB '리보세라닙' 미국 진출기]불발된 국산 항암제 첫 미국 진출, FDA 사실상 '승인 거절'